NCT06533657 2026-03-12
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2 Active not recruiting
Clinical Trials
13 trialsNCT06731894 2025-12-05
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
City of Hope Medical Center
Phase 2 Recruiting
NCT03948074 2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2 Completed
NCT06601218 2025-06-24
Impact of Daily Oral Cannabis Doses in Patients With Cancer
University of Kentucky
Phase 1 Recruiting
NCT03984214 2025-04-10
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase 3 Completed
NCT06518434 2024-07-24
CanHep
University Medical Center Groningen
Phase 2 Recruiting
NCT00674609 2023-05-03
SPRAY
Jazz Pharmaceuticals
Phase 3 Completed
NCT05272865 2023-02-01
Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC
LaSanta S A S
Phase 1/2 Unknown
NCT04155008 2022-11-16
Nutrition and Pharmacological Algorithm for Oncology Patients Study
Montefiore Medical Center
Phase 4 Terminated
NCT03661892 2021-04-29
Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets
University of Arizona
Phase EARLY_PHASE1 Completed
NCT00553059 2020-10-09
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00314808 2014-07-16
A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas
Duke University
Phase 1 Completed
NCT00316563 2010-02-09
Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
AHS Cancer Control Alberta
Phase 2 Completed